XTLB
XTL Biopharmaceuticals Ltd ADR
NASDAQ: XTLB · HEALTHCARE · BIOTECHNOLOGY
$3.90
+9.55% today
Updated 2026-04-30
Market cap
$5.65M
P/E ratio
—
P/S ratio
5.84x
EPS (TTM)
$-3.60
Dividend yield
—
52W range
$2 – $10
Volume
2.3M
WallStSmart proprietary scores
25
out of 100
Grade: F
Strong Sell
Investment rating
2.7
Growth
F4.5
Quality
C2.5
Profitability
F5.0
Valuation
C+2/9
Piotroski F-Score
Weak
-25.5
Altman Z-Score
Distress
—
Industry rank
—
View all highly rated stocks (75+) →201 stocks currently score above 75
Price targets
Analyst target
$30.00
+669.23%
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
Price chart
X-Ray snapshot
Strengths
+ Debt/equity 0.03x — low leverage
Risks
- Piotroski 2/9 — weak financial health
- Altman Z -25.49 — distress zone
- Thin margins at 0.00%
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2021 | 2022 | 2023 | 2024 | TTM |
|---|---|---|---|---|---|
| Revenue | $1.47M | $-459000.00 | $0.00 | $451000.00 | $968000.00 |
| Net income | $435000.00 | $-1.35M | $-1782.00 | $-1.03M | $-255000.00 |
| EPS | — | — | — | — | $-3.60 |
| Free cash flow | $-1.05M | $-901000.00 | $-707000.00 | $-1.67M | — |
| Profit margin | 29.67% | 293.68% | — | -227.72% | — |
Peer comparison
Smart narrative
XTL Biopharmaceuticals Ltd ADR trades at $3.90. Our Smart Value Score of 25/100 indicates the stock is weak. The company scores 2/9 on the Piotroski F-Score. With an Altman Z-Score of -25.49, it sits in the distress. TTM revenue stands at $968000.00.
Frequently asked questions
What is XTL Biopharmaceuticals Ltd ADR's stock price?
XTL Biopharmaceuticals Ltd ADR (XTLB) trades at $3.90.
Is XTL Biopharmaceuticals Ltd ADR overvalued?
Smart Value Score 25/100 (Grade F, Strong Sell).
What is the price target of XTL Biopharmaceuticals Ltd ADR (XTLB)?
The analyst target price is $30.00, representing +669.2% upside from the current price of $3.90.
What is XTL Biopharmaceuticals Ltd ADR's revenue?
TTM revenue is $968000.00.
Piotroski F-Score?
2/9 — weak financial health.
Altman Z-Score?
-25.49 — distress.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio5.84x
ROE-577.00%
Beta0.68
50D MA$2.70
200D MA$4.07
Shares out0.00B
Float0.27B
Short ratio—
Avg volume2.3M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—